Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

This publication has 24 references indexed in Scilit:

• Safety, immunogenicity and efficacy of one or three doses of the Rhesus tetravalent rotavirus vaccine in Lima, Peru
  Vaccine, 1992
• Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: Review
  Clinical Infectious Diseases, 1991
• A Field Study of the Safety and Efficacy of Two Candidate Rotavirus Vaccines in a Native American Population
  The Journal of Infectious Diseases, 1991
• Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults
  Vaccine, 1990
• Recombinant attenuated Vibrio cholerae strains used as live oral vaccines
  Research in Microbiology, 1990
• SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR
  The Lancet, 1988
• TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTS
  The Lancet, 1987
• FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINE
  The Lancet, 1986
• A Recombinant Live Oral Cholera Vaccine
  Nature Biotechnology, 1984
• ORAL POLIO VACCINATION OF CHILDREN IN THE TROPICS: I. THE POOR SEROCONVERSION RATES AND THE ABSENCE OF VIRAL INTERFERENCE
  American Journal of Epidemiology, 1972